𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

✍ Scribed by Takahiro Yamasaki; Teruaki Kimura; Fumie Kurokawa; Kouji Aoyama; Tsuyoshi Ishikawa; Kunihiko Tajima; Yuichiro Yokoyama; Taro Takami; Kaoru Omori; Kotaro Kawaguchi; Masako Tsuchiya; Shuji Terai; Isao Sakaida; Kiwamu Okita

Publisher
Springer Japan
Year
2005
Tongue
English
Weight
708 KB
Volume
40
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic factors in patients with hepa
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy
✍ Shuichi Okada; Nobuo Okazaki; Haruhiko Nose; Masayoshi Yoshimori; Kazunori Aoki πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 602 KB

A total of 71 consecutive patients with unresectable hepatocellular carcinoma were analyzed retrospectively to determine the significant prognostic factors. All the patients received systemic chemotherapy in a phase 2 study from 1980 to 1990, with no other anticancer treatment. Median survival time

Repetitive short-course hepatic arterial
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
✍ Jun Yong Park; Sang Hoon Ahn; Young Joon Yoon; Ja Kyung Kim; Hyun Woong Lee; Do πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 155 KB

## Abstract ## BACKGROUND. Hepatic arterial infusion chemotherapy (HAIC) has often been selected as a therapeutic option for patients with advanced hepatocellular carcinoma (HCC). The objective of the current study was to evaluate the efficacy and safety of repetitive HAIC with high‐dose 5‐fluorou